As of Jul 29
| +2.94 / +2.56%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 125.00, with a high estimate of 145.00 and a low estimate of 101.00. The median estimate represents a +5.96% increase from the last price of 117.97.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.